Announcements Trials
Browse Landscape

Phase

Phase NA 36Phase 4 31Phase 2 19Phase 3 16Phase 2/3 4Phase 1/2 4Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Pain, Postoperative 2Prostatic Neoplasms 1Lung Neoplasms 1Immune System Suppression 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Bupivacaine × Clear all
NCT04033471 2021-02-24

Combined Epidural Morphine and Midazolam on Postoperative Pain

Assiut University

Phase 1/2 Unknown
20 enrolled

Pain, Postoperative

NCT03024957 2021-01-14

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Assiut University

Phase 1/2 Unknown
30 enrolled

Immune System Suppression

NCT03560362 2018-06-20

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

University of Tennessee

Phase 1/2 Unknown
50 enrolled
Thoracic

Lung Neoplasms, Pain, Postoperative

NCT01565512 2015-03-05

Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort

Columbia University

Phase 1/2 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡